Bioasas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 11,471 | 7,480 | - | 300 | 5,320 | 11,500 | 18,000 | 18,980 |
| Profit before tax | 2,076 | 650 | -4,478 | -3,361 | -53 | - | -556 | -413 |
| Net profit | 1,950 | 617 | -4,478 | -3,361 | -53 | -301 | -556 | -413 |
| Equity | 1,706 | 2,323 | -2,155 | -5,517 | 0 | -5,871 | -6,426 | -6,839 |
| Liabilities | - | - | - | - | 9,535 | 7,680 | 7,816 | 7,768 |
| Non-current assets | 4,576 | 3,961 | 3,345 | 444 | 258 | 88 | 2 | 2 |
| Current assets | 2,099 | 5,081 | 3,187 | 3,215 | 3,708 | 1,721 | 1,388 | 927 |
| Total assets | 6,675 | 9,042 | 6,532 | 3,659 | 3,966 | 1,809 | 1,390 | 929 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,106 | 2,965 | 3,000 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -58.6% | -34.8% | - | - | +1673.3% | +116.2% | +56.5% | +5.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 29.2% | 6.8% | -68.6% | -91.9% | -1.3% | -16.6% | -40.0% | -44.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 114.3% | 26.6% | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.0% | 8.2% | - | -1120.3% | -1.0% | -2.6% | -3.1% | -2.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.1% | 8.7% | - | -1120.3% | -1.0% | - | -3.1% | -2.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioasas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-01 | 2026-07-31 | 45.23 |
| 2026-06-02 | 2026-06-30 | 48.75 |
| 2026-05-03 | 2026-05-31 | 48.95 |
| 2026-04-20 | 2026-04-30 | 60.90 |
| 2026-04-01 | 2026-04-19 | 141.38 |
| 2026-03-06 | 2026-03-31 | 60.90 |
| 2026-03-03 | 2026-03-05 | 111.64 |
| 2026-02-13 | 2026-03-02 | 31.16 |
| 2026-02-03 | 2026-02-12 | 47.21 |
| 2026-01-01 | 2026-01-31 | 46.73 |
| 2025-12-08 | 2025-12-31 | 135.28 |
| 2025-12-02 | 2025-12-07 | 47.93 |
| 2025-11-05 | 2025-11-30 | 136.48 |
| 2025-11-01 | 2025-11-04 | 49.13 |
| 2025-10-01 | 2025-10-31 | 137.68 |
| 2025-09-03 | 2025-09-30 | 138.88 |
| 2025-09-02 | 2025-09-02 | 51.53 |
| 2025-08-04 | 2025-08-31 | 140.08 |
| 2025-08-01 | 2025-08-03 | 52.73 |
| 2025-07-03 | 2025-07-31 | 105.28 |
| 2025-07-01 | 2025-07-02 | 17.93 |
| 2025-06-04 | 2025-06-30 | 120.48 |
| 2025-06-03 | 2025-06-03 | 33.13 |
| 2025-05-07 | 2025-05-31 | 25.68 |
| 2024-10-01 | 2024-10-31 | 72.89 |
| 2024-09-04 | 2024-09-30 | 73.64 |
| 2024-07-03 | 2024-07-31 | 75.14 |
| 2024-06-05 | 2024-06-30 | 75.89 |
| 2023-07-19 | 2023-07-31 | 69.51 |
Bioasas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-28 | 2025-04-30 | 249.45 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioasas, MB (code 304436806) is a Small partnership engaged in intermediation service activities for business support services n.e.c. In 2025, revenue increased to €19.0K, up 5.4% year on year and 65.0% compared with 2023, when revenue was €11.5K. The company remained loss-making, posting net profit of -€413 in 2025 after -€556 in 2024 and -€301 in 2023. Even so, the profit margin improved to -2.2% in 2025 from -3.1% in 2024. The balance sheet stayed under pressure: total assets declined to €929 in 2025 from €1.4K in 2024 and €1.8K in 2023, while equity remained negative at -€6.8K and liabilities were €7.8K. Long-term assets were only €2, so nearly all assets were current. Asset turnover was high at 20.43x, reflecting the very small asset base. The reported ROA was -44.5%, and profitability indicators should be viewed in the context of the company’s negative equity position.